Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder August 31, 2023August 31, 2023
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 November 16, 2023November 16, 2023
Pre-clinical evidence demonstrates PBT434 as a potential treatment for MSA October 5, 2018August 16, 2022
